Gemcitabine

Pancreatic cancer remains one of the most challenging cancers to treat due to its aggressive nature and late diagnosis in many patients. Recent advances in oncology have introduced combination chemotherapy strategies designed to improve survival rates and reduce recurrence after surgical resection. Among these strategies, the use of Xeloda (capecitabine) and gemcitabine as adjuvant therapy … Read more